Blue Ruin by Hari Kunzru review – art monsters From the galleries and squats of 90s London to Covid-era New York, a tale of fame and fallout The Guardian - UK · May 9, 2024
Bank Of England To Test Rate Cut Assumptions Bank of England testing negative interest rates to assess impact on UK economy amidst COVID-19 challenges. Top News · May 9, 2024
TOI Health News Morning Briefing | AstraZeneca withdraws COVID vaccine, West Nile fever outbreak, pregnancy guide for summer season, fitness tips and more AstraZeneca withdraws COVID vaccine worldwide The Times of India · May 9, 2024
US Fuel Demand Hits Pandemic Lows, Affects Refining Margins Learn how the COVID-19 pandemic has led to a significant drop in fuel demand in the US, impacting refining margins and requiring refineries to innovate and... Top News · May 8, 2024
Uber Forecasts Lower-Than-Expected Gross Bookings For Second Quarter Uber's Q2 gross bookings fall short of expectations due to COVID-19 impact, but company remains optimistic about future growth. Top News · May 8, 2024
AstraZeneca withdraws Covid vaccine worldwide due to 'surplus' The pharma giant says the decision was made due to the availability of superior vaccines Evening Standard · May 8, 2024
AstraZeneca Withdraws Covid Vaccine As Demand Dives Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing Covid vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing "commercial reasons" following a slump in demand. International Business Times · May 8, 2024
Welsh first minister rejects Covid inquiry perjury claims Vaughan Gething expresses regret over donations scandal amid anger over separate allegations about deleted messages The Guardian - UK · May 8, 2024
Japan Supports Boe With June Rate Cut Japan supports Bank of England with potential rate cut amid COVID-19 economic uncertainty, reflecting international cooperation for global stability. Top News · May 8, 2024
AstraZeneca withdraws COVID-19 vaccine worldwide, cites commercial reasons The pharmaceutical giant AstraZeneca's COVID-19 vaccine is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous side effect, according to a report in the British Newspaper 'The Telegraph'. Read further on Dynamite News: Dynamite News · May 8, 2024
AstraZeneca withdraws COVID vaccine worldwide weeks after admitting rare side effects British pharmaceutical company AstraZeneca is currently withdrawing its COVID vaccine worldwide, months after it admitted for the first time in court documents that it can cause a rare and dangerous side effect, The Telegraph reported. The Times of India · May 8, 2024
AstraZeneca withdraws Covid-19 vaccine worldwide, citing surplus of newer vaccines Pharmaceutical company says newer shots led to decline in demand for AstraZeneca vaccine, which is no longer being manufactured or supplied The Guardian - AU · May 8, 2024
Opioid treatment drug offers hope for long COVID cases A drug that has been on the market to treat opioid addiction can potentially be used to alleviate debilitating illnesses like long COVID, researchers say. AAP · May 7, 2024
Victoria state budget 2024 winners and losers: $400 for school students, home buyer fund boost and increased levies Government to expand shared-equity scheme for home buyers but will delay long-awaited airport train The Guardian - AU · May 7, 2024
The Hindu · May 7, 2024 Flexible office spaces reshape post-COVID work environments COVID-19 has transformed India's office space landscape, leading to a surge in flexible office arrangements and hybrid work models.
The Guardian - UK · May 6, 2024 Heineken to pump £39m into reopening and revamping UK pubs Firm aims to upgrade 612 outlets and reopen 62 this year amid signs of rising consumer confidence
The Guardian - UK · May 6, 2024 Scientists create vaccine with potential to protect against future coronaviruses Researchers say experimental shot is step towards goal of creating vaccines before a pandemic has started
The Times of India · May 6, 2024 The crucial role of accountability in healthcare: Lessons from the Covishield vaccine In recent times, the field of healthcare has been under scrutiny like never before. The COVID-19 pandemic has not only brought medical challenges but has also highlighted the critical need for accountability in the healthcare field. AstraZeneca's statement regarding rare adverse effects related to blood clotting associated with its COVID-19…
Salon · May 6, 2024 Can we bridge the science-trust gap? Partisan furor and COVID-19 highlighted a deadly distrust in science. But a leading scientist sees a path forward
Al Jazeera · May 6, 2024 ‘Destruction of jobs’: India election turns spotlight on a dream gone sour India’s workforce is becoming more informalised and the quality of employment has suffered since the COVID-19 pandemic.
Top News · May 5, 2024 Pompeo Shared Intel Suggesting COVID-19 Lab Leak To UK Former U.S. Secretary of State shared intelligence with the U.K. suggesting a lab leak origin of COVID-19, leading to calls for a criminal investigation in...
The Hindu · May 5, 2024 Strict action over attacks on nurses: Minister V. Sivankutty Kerala government vows to take strict action against attacks on nurses, highlighting their invaluable contributions during COVID-19.
The Hindu · May 5, 2024 Lokesh has 23 criminal cases pending against him, says declaration TDP candidate Nara Lokesh faces 23 criminal cases, including corruption, defamation, and violating Covid-19 guidelines, as per Supreme Court judgments.
The Times of India · May 5, 2024 FLiRT, the new COVID variants are circulating fast: All about symptoms, severity COVID is still there among us and recently two new variants have been found in the US. Termed as the "FLiRT" these two variants include KP.2 which overtook the JN.1 subvariant of Omicron in recent weeks. As per the latest data from the U.S. Centers for Disease Control and Prevention,…
The Hindu · May 4, 2024 No adverse effects reported from COVID vaccines in India: V. K. Saraswat No adverse effects have been reported in India with regard to the vaccines used for battling COVID-19, senior scientist and NITI Aayog member V. K. Saraswat said here on Saturday.